Laboratory markers for COPD in "susceptible" smokers

Clinica Chimica Acta

Volumn 364, Issue 1-2, 2006, Pages 124-138

  Tzortzaki, Eleni G ^a   Tsoumakidou, Maria ^a   Makris, Demosthenes ^a   Siafakas, Nikolaos M ^a  

^a UNIVERSITY OF CRETE   (Greece)

Author keywords

Chronic obstructive pulmonary disease; Genetics; Inflammatory mediators; Microsatellite DNA; Proteases antiproteases; Screening

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; ALPHA 1 ANTITRYPSIN; ALPHA 2 MACROGLOBULIN; BIOLOGICAL MARKER; BLOOD GROUP ANTIGEN; COPPER ZINC SUPEROXIDE DISMUTASE; CYTOCHROME P450 1A1; EPOXIDE HYDROLASE; GELATINASE B; GLUTATHIONE TRANSFERASE; HLA ANTIGEN; IMMUNOGLOBULIN; INTERLEUKIN 1; INTERLEUKIN 11; INTERLEUKIN 13; LYMPHOTOXIN; MATRIX METALLOPROTEINASE; MICROSATELLITE DNA; NEUROKININ A; NEUTROPHIL COLLAGENASE; PROTEINASE ACTIVATED RECEPTOR 2; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR; SUBSTANCE P; TACHYKININ; TRANSFORMING GROWTH FACTOR BETA1; TRANSMEMBRANE CONDUCTANCE REGULATOR; TUMOR NECROSIS FACTOR ALPHA; VITAMIN D BINDING PROTEIN;

AIRWAY; BLOOD ANALYSIS; BRONCHUS BIOPSY; CHRONIC OBSTRUCTIVE LUNG DISEASE; EOSINOPHIL; EXHALATION; GENETIC SUSCEPTIBILITY; HEREDITY; HUMAN; LUNG FUNCTION; LYMPHOCYTE; MICROSATELLITE INSTABILITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SMOKING; SPUTUM ANALYSIS; URINALYSIS;

BIOLOGICAL MARKERS; BRONCHOALVEOLAR LAVAGE FLUID; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MICROSATELLITE REPEATS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING; SPUTUM;

EID: 31044450592     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2005.06.008     Document Type: Review

References (167)

1. B.R. Celli, and W. MacNee Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS paper Eur Respir J 23 6 2004 932 946
2. American Thoracic Society Cigarette smoking and health Am J Respir Crit Care Med 153 2 1996 861 865
3. R.M. Davis, and T.E. Novotny The epidemiology of cigarette smoking and its impact on chronic obstructive pulmonary disease Am Rev Respir Dis 140 1989 S82 S84
4. B. Burrows, R.J. Knudson, M.G. Cline, and M.D. Lebowitz Quantitative relationships between cigarette smoking and ventilatory function Am Rev Respir Dis 115 2 1977 195 205
5. S.T. Weiss, D.L. DeMeo, and D.S. Postma COPD: problems in diagnosis and measurement Eur Respir J 21 Suppl. 41 2003 4s 12s
6. A.B. Valkey Chronic obstructive pulmonary disease in women: exploring gender differences Curr Opin Pulm Med 10 2004 98 103
7. D.R. Quellete The answer is fifteen percent. What is the question? Chest 125 2004 3 5
8. D.A. Spandidos, M. Ergazaki, and J. Hatzistamou Microsatellite instability in patients with chronic obstructive pulmonary disease Oncol Rep 3 1996 489 491
9. N.M. Siafakas, E.G. Tzortzaki, and G. Sourvinos Microsatellite DNA instability in COPD Chest 116 1999 47 51
10. M. Zervou, E.G. Tzortzaki, and D. Makris Differential diagnosis of COPD and Asthma at the Microsatellite DNA level [abstract] Eur Respir J 24 2004 694s
11. B. Rijcken, J.P. Schouten, and S.T. Weiss The association between airways responsiveness to respiratory symptom prevalence and to pulmonary function in a random population sample Bull Eur Physiopathol Respir 23 1987 391 394
12. J.J. Hospers, D.S. Postma, and B. Rijchen Histamine airway hyper-responsiveness and mortality from chronic obstructive pulmonary disease: a cohort study Lancet 356 2000 1313 1317
13. S.B. Mazzone Targeting tachykinins for the treatment of obstructive airways disease Treat Respir Med 3 4 2004 201 216
14. P. Boschetto, D. Miotto, and I. Bononi Sputum substance P and neurokinin A are reduced during exacerbations of chronic obstructive pulmonary disease Pulm Pharmacol Ther 18 3 2005 199 205
15. L. Joos, T.D. Weir, and J.E. Connett Polymorphisms in the beta2 adrenergic receptor and bronchodilator response, bronchial hyperresponsiveness, and rate of decline in lung function in smokers Thorax 58 8 2003 (Aug) 703 707
16. I.B. Tager, B. Rosner, and P.V. Tishler Household aggregation of pulmonary function and chronic bronchitis Am Rev Respir Dis 114 1976 485 492
17. S. Redline, P.V. Tishler, and F.I. Lewitter Assessment of genetic and nongenetic influences on pulmonary function Am Rev Respir Dis 135 1987 217 222
18. E.K. Silverman, and F.E. Speizer Risk factors for the development of chronic obstructive pulmonary disease Med Clin North Am 80 1996 501 522
19. P.J. Barnes Molecular genetics of chronic obstructive pulmonary disease Thorax 54 1999 245 252
20. I. Potempa, E. Korzus, and I. Travis The serpin superfamily of proteinase inhibitors: structure, function, and regulation J Biol Chem 269 1994 15957 15960
21. C.P. Hersh, D.L. DeMeo, and C. Lange Attempted replication of reported chronic obstructive pulmonary disease candidate gene associations Am J Respir Cell Mol Biol 33 1 2005 71 78
22. A.J. Sandford, and P.D. Pare Genetic risk factors for chronic obstructive pulmonary disease Clin Chest Med 21 2000 633 643
23. N.A. Molfino Genetics of COPD Chest 125 2004 1929 1940
24. E.D. Janus, N.T. Phillips, and R.W. Carrell Smoking, lung function and alpha1-antitrypsin deficiency Lancet i 1985 152 154
25. M.L. Brantley, L.D. Paul, and B.H. Miller Clinical features and history of the destructive lung disease associated with alpha1-antitrypsin deficiency of adults with pulmonary symptoms Am Rev Respir Dis 138 1988 327 336
26. M.J. Tobin, P.J.L. Cook, and D.C.S. Hutchinson Alpha1-antitrypsin deficiency: the clinical and physiological features of pulmonary emphysema in subjects homozygous for Pi type Z: a survey by the British Thoracic Association Br J Dis Chest 77 1983 14 27
27. M.L. O'Brien, N.R.M. Buist, and H.W. Murphey Neonatal screening for alpha1-antitrypsin deficiency J Pediatr 92 1978 1006 1010
28. S.F. Tattersall, R.P. Pereira, and D. Hunter Lung dispensability and airway function in intermediate alpha1-antitrypsin deficiency Thorax 34 1979 637 646
29. L.F. Black, and F. Kueppers Alpha1-antitrypsin deficiency in nonsmokers Am Rev Respir Dis 117 1978 421 428
30. E. Tarjan, P. Magyar, and Z. Vaczi Longitudinal lung function study in heterozygous PiMZ phenotype subjects Eur Respir J 7 1994 2199 2204
31. M.C. Owen, S.O. Brennan, and J.H. Lewis Mutation of antitrypsin to antithrombin: a1-antitrypsin Pittsburgh (358 met→arg), a fatal bleeding disorder N Engl J Med 309 1983 694 698
32. M. Dahl, B.G. Nordestgaard, P. Lange, J. Vestbo, and A.T. Tybjaerg-Hansen Molecular diagnosis of intermediate and severe a1-antitrypsin deficiency: MZ individuals with chronic obstructive pulmonary disease may have lower lung function than MM individuals Clin Chem 47 2001 56 62
33. G.M. Turino, A.F. Barker, and M.L. Brantly Clinical features of individuals with PI*SZ phenotype of a1-antitrypsin deficiency Am J Respir Crit Care Med 154 1996 1718 1725
34. W. Poller, J.-B. Faber, and S. Scholz Mis-sense mutation of a1-antichymotrypsin gene associated with chronic lung disease Lancet 339 1992 1538
35. M.G. Bentazzo, L.S. Gile, and C. Bombieri a1-antitrypsin Taq1 polymorphism and a1-antichymotrypsin mutations in patients with obstructive pulmonary disease Respir Med 93 1999 648 654
36. S. Eriksson, B. Lindmark, and H. Liljia Familial a1-antichymotrypsin deficiency Acta Med Scand 220 1986 447 453
37. W. Poller, J. Barth, and B. Voss Detection of an alteration of the a2-macroglobulin gene in a patient with chronic lung disease and serum a2-macroglobulin deficiency Hum Genet 83 1989 93 96
38. J.-M. Sallenave, J. Shulmann, and J. Crossley Regulation of secretory leukocyte proteinase inhibitor (SLPI) and elastase-specific inhibitor (ESI/Elafin) in human airway epithelial airway cells by cytokines and neutrophilic enzymes Am J Respir Cell Mol Biol 11 1994 733 741
39. T. Abe, N. Kobayashi, and K. Yoshimura Expression of the secretory leukoprotease inhibitor gene in epithelial cells J Clin Invest 87 1991 2207 2215
40. S. Gompertz, D.L. Bayley, S.L. Hill, and R.A. Stockley Relationship between airway inflammation and the frequency of exacerbations in patients with smoking related COPD Thorax 56 2001 36 41
41. J.H. Vernooy, J.H. Lindeman, J.A. Jacobs, R. Hanemaaijer, and E.F. Wouters Increased activity of matrix metalloproteinase-8 and matrix metalloproteinase-9 in induced sputum from patients with COPD Chest 126 6 2004 (Dec) 1802 1810
42. D. Miotto, M.D. Hollenberg, and N.W. Bunnett Expression of protease activated receptor-2 (PAR-2) in central airways of smokers and non-smokers Thorax 57 2002 146 151
43. M. Saetta, G. Turato, and R. Zuin Structural basis for airflow limitation in chronic obstructive pulmonary disease Sarcoidosis Vasc Diffuse Lung Dis 17 2000 239 245
44. C.A. Smith, and D.J. Harrison Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema Lancet 350 1997 630 633
45. L. Joos, P.D. Pare, and A.J. Sandford Genetic risk factors for chronic obstructive pulmonary disease Swiss Med Wkly 132 2002 27 37
46. T. Ishii, T. Matsuse, and S. Teramoto Glutathione S-transferase P1(GSTP1) polymorphism in patients with chronic obstructive pulmonary disease Thorax 54 1999 693 696
47. A.M. Cantlay, D. Lamb, and M. Gillooly Association between the CYP1A1 gene polymorphism and susceptibility to emphysema and lung cancer J Clin Pathol Mol Pathol 48 1995 M210 M214
48. T. Harju, R. Kaarteenaho-Wiik, R. Sirvio, and P. Paakko Manganese superoxide dismutase is increased in the airways of smokers' lungs Eur Respir J 24 5 2004 765 771
49. L.M. Jonsson, T. Edlund, S.L. Marklund, and T. Sandstrom Increased ozone-induced airway neutrophilic inflammation in extracellular-superoxide dismutase null mice Respir Med 96 4 2002 209 214
50. J. Sandstrom, P. Nilsson, and K. Karlsson Tenfold increase in human plasma extracellular superoxide dismutase content caused by a mutation in heparin-binding domain J Biol Chem 268 1994 19163 19166
51. R. Gervais, J.J. Lafitte, and V. Dumur Sweat chloride and DF508 mutation in chronic bronchitis or bronchiectasis Lancet 342 1993 997
52. M. Tsetis, A. Efthymiadou, and S. Strofalis CFTR gene mutations-including three novel nucleotide substitutions- and haplotype background in patients with asthma, disseminated bronchiectasis and chronic obstructive pulmonary disease Hum Genet 108 2001 216 221
53. N. Yamamoto, and S. Homma Vitamin D-binding protein (group-specific component) is a precursor for the macrophage-activating signal factor from lysophosphatidyl-cholin-treated lymphocytes Proc Natl Acad Sci U S A 88 1991 8539 8543
54. R.R. Kew, and R.O. Webster Gc-globulin (vitamin D-binding protein) enhances the neutrophil chemotactic aticity of C5a and C5a des Arg J Clin Invest 82 1988 364 369
55. J.P. Metcalf, A.B. Thompson, and G.L. Gossman GcGlobulin functions as a cochemotaxin in the lower respiratory tract Am Rev Respir Dis 143 1991 844 849
56. D. Schellenberg, P. Pare, and T.D. Weir Vitamin D binding protein variants and the risk of COPD Am J Respir Crit Care Med 157 1998 957 961
57. S.L. Horne, D.W. Cockcroft, and J.A. Dosman Possible protective effect against chronic obstructive pulmonary disease by the GC2 allele Hum Hered 40 1990 173 176
58. I. Ito, S. Nagai, and Y. Hoshino Risk and severity of COPD is associated with the group-specific component of serum globulin 1F allele Chest 125 2004 63 70
59. I. Ferrarotti, M. Zorzetto, and M. Beccaria Tumour necrosis factor family genes in a phenotype of COPD associated with emphysema Eur Respir J 21 2003 444 449
60. W. Klein, G. Rohde, and U. Arinir A promoter polymorphism in the Interleukin 11 gene is associated with chronic obstructive pulmonary disease Electrophoresis 25 2004 804 808
61. L. Joos, L. McIntyre, and J. Ruan Association of IL-1 beta and IL-1 receptor antagonist haplotypes with rate of decline in lung function in smokers Thorax 56 2001 863 866
62. T. Ishii, T. Matsuse, and S. Teramoto Neither IL-1beta, IL-1 receptor antagonist, nor TNF-alpha polymorphisms are associated with susceptibility to COPD Respir Med 94 2000 847 851
63. T.C. van der Pouw Kraan, M. Kucukaycan, and A.M. Bakker Chronic obstructive pulmonary disease is associated with the -1055 IL-13 promoter polymorphism Genes Immun 3 7 2002 (Nov) 436 439
64. R.C. Hu, Y.J. Xu, and Z.X. Zhang Study on the correlation of interleukin-13 polymorphism and susceptibility to chronic obstructive pulmonary disease in Chinese Han population Zhonghua Liu Xing Bing Xue Za Zhi 25 7 2004 607 611
65. J.C. Celedon, C. Lange, and B.A. Raby The transforming growth factor-beta1 (TGFB1) gene is associated with chronic obstructive pulmonary disease (COPD) Hum Mol Genet 13 15 2004 1649 1656
66. V. Popa, K. Kim, and D.C. Heiner IgG deficiency in adults with recurrent respiratory infections Ann Allergy 70 5 1993 (May) 418 424
67. M.W. Higgins, J.B. Keller, and M. Becker An index of risk for obstructive airways disease Am Rev Respir Dis 125 1982 144 151
68. J. Vestbo, H.O. Hein, and P. Suadicani Genetic markers for chronic bronchitis and peak expiratory flow in the Copenhagen Male Study Dan Med Bull 40 1993 378 380
69. S.L. Horne, D.W. Cockcroft, and A. Lovegrove ABO, Lewis and secretor status and relative incidence of airflow obstruction Dis Markers 3 1985 55 62
70. B.H. Cohen, W.B. Bias, and G.A. Chase Is ABH non-secretor status a risk factor for obstructive lung disease? Am J Epidemiol 111 1980 285 291
71. R.T. Abboud, P. Yu, and M. Chan-Yeung Lack of relationship between ABH secretor status and lung function in pulp-mill workers Am Rev Respir Dis 126 1982 1089 1091
72. H. Recalde, M. Cuccia, T. Oggionni, E. Dondi, M. Martinetti, and M. Luisetti Lymphocyte expression of human leukocyte antigen class II molecules in patients with chronic obstructive pulmonary disease Monaldi Arch Chest Dis 54 5 1999 384 389
73. C. Schlotterer, and D. Tautz Slippage synthesis of simple sequence DNA Nucleic Acids 20 1992 211 215
74. R.D. Kolodner, and G.T. Marsischky Eukaryotic DNA mismatch repair Curr Opin Genet Dev 9 1999 89 96
75. G. Aquilina, and M. Bignami Mismatch repair in correction of replication errors and processing of DNA damage J Cell Physiol 187 2001 145 154
76. M.R. Hussein, and G.S. Wood Building bridges in cancer: mismatch repair and microsatellite instability Am J Dermatopathol 24 2002 76 81
77. S. Markowitz, J. Wang, and L. Mycroff Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability Science 268 1995 1336 1338
78. P. Peltomaki, R.A. Lothe, and L.A. Aaltonen Microsatellite instability is associated with tumors that characterize the hereditary non-polyposis colorectal carcinoma syndrome Cancer Res 53 1993 5853 5855
79. S.N. Thibodeau, G. Bren, and D. Schaid Microsatellite instability in cancer of the proximal colon Science 260 1993 816 819
80. R. Gryfe, H. Kim, and E.T.K. Hsieh Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer N Engl J Med 342 2000 69 77
81. M. Froudarakis, G. Sourvinos, and P. Fournel Microsatellite instability and loss of heterozygosity at chromosomes 9 and 17 in non-small cell lung cancer Chest 113 1998 1091 1094
82. W.K. Leung, J.J. Kim, and J.G. Kim Microsatellite instability in gastric intestinal metaplasia in patients with and without gastric cancer Am J Pathol 156 2000 537 543
83. J.I. Risinger, A. Berchuck, and M.F. Kohler Genetic instability of microsatellites in endometrial carcinoma Cancer Res 53 1993 5100 5103
84. C.J. Yee, N. Roodi, and C.S. Verrier Microsatellite instability and loss of heterozygosity in breast cancer Cancer Res 54 1994 1641 1644
85. C. Goessl, M. Muller, and B. Straub DNA alterations in body fluids as molecular tumor markers for urologic malignancies Eur Urol 41 2002 668 676
86. J.K. Field, H. Kiaris, and P. Howard Microsatellite instability in squamous cell carcinoma of the head and neck Br J Cancer 71 1995 1065 1069
87. M.M. Kroiss, T.M. Vogt, and J. Schlegel Microsatellite instability in malignant melanomas Acta Derm Venereol 81 2001 242 245
88. L. Girard, S. Zochbauer-Muller, and A.K. Virmani Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering Cancer Res 60 2000 4894 4906
89. I.I. Wistuba, C. Behrens, and A.K. Virmani Allelic losses at chromosome 8p21-23 is early and frequent events in the pathogenesis of lung cancer Cancer Res 59 1999 1973 1979
90. D.A. Arvanitis, E. Papadakis, and A. Zafiropoulos Fractional allele loss is a valuable marker for human lung cancer detection in sputum Lung Cancer 40 2003 55 66
91. P.J. White, R.H. Borts, and M.C. Hirst Stability of the human fragile X (CGG)n triplet repeat array in Saccharomyces cerevisiae deficient in aspects of DNA metabolism Mol Cell Biol 19 1999 5675 5684
92. D.C. Rubinsztein, J. Leggo, and G.TA. Coetzee Sequence variation and size ranges of CAG repeats in the Machado-Joseph disease, spinocerebellar ataxia type 1 and androgen receptor genes Hum Mol Genet 4 1995 1585 1590
93. T. Fujisawa, H. Ikegami, and Y. Kawaguchi Length rather than a specific allele of dinucleotide repeat in the 5′ upstream region of the aldose reductase gene is associated with diabetic retinopathy Diabet Med 16 1999 1944 1947
94. M. Awad, V. Pravica, and C. Perrey CA repeat all polymorphism in the first intron of the human interferon-gamma gene is associated with lung allograft fibrosis Hum Immunol 60 1999 343 346
95. E.T. Detorakis, G. Sourvinos, and J. Tsamparlakis Evaluation of loss of heterozygosity and microsatellite instability in human pterygium: clinical correlations Br J Ophthalmol 82 1998 1324 1328
96. I. Rehman, A.G. Quinn, and E. Healy High frequency of loss of heterozygosity in actinic keratoses, a usually benign disease Lancet 344 1994 788 789
97. J. Hatzistamou, H. Kiaris, and M. Ergazaki Loss of heterozygosity and microsatellite instability in human atherosclerotic plaques Biochem Biophys Res Commun 225 1996 186 190
98. G. Zachos, E. Koumantaki, and A. Vareltzidis Evidence for loss of heterozygosity in human psoriatic lesion Br J Dermatol 139 1998 974 977
99. V.P. Kozobolis, E.T. Detorakis, and G. Sourvinos Loss of heterozygosity in pseudoexfoliation syndrome Invest Ophthalmol Vis Sci 40 1999 1255 1260
100. S.H. Lee, D.K. Chang, and A. Goel Microsatellite instability and suppressed DNA repair enzyme expression in Rheumatoid Arthritis J Immunol 170 2003 2214 2220
101. M.R. Maduro, R. Casella, and E. Kim Microsatellite instability and defects in mismatch repair proteins: a new etiology for Sertoli cell-only syndrome N Engl J Med 9 2003 61 68
102. H. Kiaris, M. Ergazaki, and D.A. Spandidos Instability at the H-ras minisatellite is associated with the spontaneous abortion of the embryo Biochem Biophys Res Commun 214 1995 788 792
103. P.S. Moore, G. Zamboni, and A. Brighenti Molecular characterization of pancreatic serous microcystic adenomas: evidence for a tumor suppressor gene on chromosome 10q Am J Pathol 158 2001 317 321
104. D.A. Spandidos, M. Ergazaki, and J. Hatzistamou Microsatellite instability in patients with chronic obstructive pulmonary disease Oncol Rep 3 1996 489 491
105. N.M. Siafakas, E.G. Tzortzaki, and G. Sourvinos Microsatellite DNA instability in COPD Chest 116 1999 47 51
106. E. Paraskakis, G. Sourvinos, and F. Passam Microsatellite DNA instability and loss of heterozygosity in bronchial asthma Eur Respir J 22 2003 951 955
107. D.A. Vassilakis, G. Sourvinos, and M. Markatos Microsatellite DNA instability and loss of heterozygosity in pulmonary sarcoidosis Am J Respir Crit Care Med 160 1999 1729 1733
108. D.A. Vassilakis, G. Sourvinos, and D.A. Spandidos Frequent genetic alterations at the microsatellite level in cytologic sputum samples of patients with Idiopathic pulmonary fibrosis Am J Respir Crit Care Med 162 2000 1115 1119
109. M. Zervou, E.G. Tzortzaki, and D. Makris Differential diagnosis of COPD and Asthma at Microsatellite DNA level [abstract] Eur Respir J 24 2004 694s
110. C. Sanders, P.H. Nath, and W.C. Bailey Detection of emphysema with computed tomography. Correlation with pulmonary function tests and chest radiography Invest Radiol 23 1988 262 266
111. G. Santis, M.E. Hodson, and B. Strickland High resolution computed tomography in adult cystic fibrosis patients with mild lung disease Clin Radiol 44 1991 20 22
112. I. Pin, P.G. Gibson, R. Kolendowicz, A. Girgis-Gabardo, J.A. Denburg, and F.E. Hargreave Use of induced sputum cell counts to investigate airway inflammation in asthma Thorax 47 1 1992 25 29
113. M. Tsoumakidou, N. Tzanakis, and N.M. Siafakas Induced sputum in the investigation of airway inflammation of COPD Respir Med 97 8 2003 863 871
114. R.O. Crapo, R.L. Jensen, and F.E. Hargreave Airway inflammation in COPD: physiological outcome measures and induced sputum Eur Respir J Suppl 41 2003 19s 28s
115. N. Tzanakis, G. Chrysofakis, M. Tsoumakidou, D. Kyriakou, J. Tsiligianni, and D. Bouros Induced sputum CD8+ T-lymphocyte subpopulations in chronic obstructive pulmonary disease Respir Med 98 1 2004 57 65
116. K.F. Chung Cytokines in chronic obstructive pulmonary disease Eur Respir J Suppl 34 2001 50s 59s
117. K.M. Beeh, J. Beier, O. Kornmann, A. Mander, and R. Buhl Long-term repeatability of induced sputum cells and inflammatory markers in stable, moderately severe COPD Chest 123 3 2003 778 783
118. J. Belda, R. Leigh, K. Parameswaran, P.M. O'Byrne, M.R. Sears, and F.E. Hargreave Induced sputum cell counts in healthy adults Am J Respir Crit Care Med 161 2 Pt 1 2000 475 478
119. D. Stanescu, A. Sanna, C. Veriter, S. Kostianev, P.G. Calcagni, and L.M. Fabbri Airways obstruction, chronic expectoration, and rapid decline of FEV1 in smokers are associated with increased levels of sputum neutrophils Thorax 51 3 1996 267 271
120. P. Maestrelli, P.G. Calcagni, M. Saetta, T. Bertin, C.E. Mapp, A. Sanna, C. Veriter, L.M. Fabbri, and D. Stanescu Integrin upregulation on sputum neutrophils in smokers with chronic airway obstruction Am J Respir Crit Care Med 154 5 1996 1296 1300
121. D. Morrison, R.M. Strieter, S.C. Donnelly, M.D. Burdick, S.L. Kunkel, and W. MacNee Neutrophil chemokines in bronchoalveolar lavage fluid and leukocyte-conditioned medium from nonsmokers and smokers Eur Respir J 12 5 1998 1067 1072
122. M. Saetta, A. Di Stefano, G. Turato, F.M. Facchini, L. Corbino, and C.E. Mapp CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease Am J Respir Crit Care Med 157 3 Pt 1 1998 822 826
123. M. Saetta, S. Baraldo, L. Corbino, G. Turato, F. Braccioni, and F. Rea CD8+ve cells in the lungs of smokers with chronic obstructive pulmonary disease Am J Respir Crit Care Med 160 2 1999 711 717
124. T.C. O'Shaughnessy, T.W. Ansari, N.C. Barnes, and P.K. Jeffery Inflammation in bronchial biopsies of subjects with chronic bronchitis: inverse relationship of CD8+ T lymphocytes with FEV1 Am J Respir Crit Care Med 155 3 1997 852 857
125. G. Chrysofakis, N. Tzanakis, D. Kyriakoy, M. Tsoumakidou, I. Tsiligianni, and M. Klimathianaki Perforin expression and cytotoxic activity of sputum CD8+ lymphocytes in patients with COPD Chest 125 1 2004 71 76
126. A. Papi, M. Romagnoli, and S. Baraldo Partial reversibility of airflow limitation and increased exhaled NO and sputum eosinophilia in chronic obstructive pulmonary disease Am J Respir Crit Care Med 162 5 2000 1773 1777
127. D.W. Perng, H.Y. Huang, H.M. Chen, Y.C. Lee, and R.P. Perng Characteristics of airway inflammation and bronchodilator reversibility in COPD: a potential guide to treatment Chest 126 2 2004 (Aug) 375 381
128. V.M. Keatings, and P.J. Barnes Granulocyte activation markers in induced sputum: comparison between chronic obstructive pulmonary disease, asthma, and normal subjects Am J Respir Crit Care Med 155 2 1997 449 453
129. A.T. Hill, D. Bayley, and R.A. Stockley The interrelationship of sputum inflammatory markers in patients with chronic bronchitis Am J Respir Crit Care Med 160 3 1999 893 898
130. S.L. Traves, S.V. Culpitt, R.E. Russell, P.J. Barnes, and L.E. Donnelly Increased levels of the chemokines GROalpha and MCP-1 in sputum samples from patients with COPD Thorax 57 7 2002 590 595
131. J.H. Vernooy, M. Kucukaycan, J.A. Jacobs, N.H. Chavannes, W.A. Buurman, and M.A. Dentener Local and systemic inflammation in patients with chronic obstructive pulmonary disease: soluble tumor necrosis factor receptors are increased in sputum Am J Respir Crit Care Med 166 9 2002 1218 1224
132. H. Kanazawa, S. Shiraishi, K. Hirata, and J. Yoshikawa Imbalance between levels of nitrogen oxides and peroxynitrite inhibitory activity in chronic obstructive pulmonary disease Thorax 58 2 2003 106 109
133. D. Cataldo, C. Munaut, A. Noel, F. Frankenne, P. Bartsch, and J.M. Foidart MMP-2- and MMP-9-linked gelatinolytic activity in the sputum from patients with asthma and chronic obstructive pulmonary disease Int Arch Allergy Immunol 123 3 2000 259 267
134. K.M. Beeh, J. Beier, O. Kornmann, and R. Buhl Sputum matrix metalloproteinase-9, tissue inhibitor of metalloprotinease-1, and their molar ratio in patients with chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis and healthy subjects Respir Med 97 6 2003 634 639
135. A. Pesci, M. Majori, A. Cuomo, N. Borciani, S. Bertacco, and G. Cacciani Neutrophils infiltrating bronchial epithelium in chronic obstructive pulmonary disease Respir Med 92 6 1998 863 870
136. A. Pesci, B. Balbi, M. Majori, G. Cacciani, S. Bertacco, and P. Alciato Inflammatory cells and mediators in bronchial lavage of patients with chronic obstructive pulmonary disease Eur Respir J 12 2 1998 380 386
137. S.R. Rutgers, W. Timens, H.F. Kaufmann, T.W. van der Mark, G.H. Koeter, and D.S. Postma Comparison of induced sputum with bronchial wash, bronchoalveolar lavage and bronchial biopsies in COPD Eur Respir J 15 1 2000 109 115
138. I.S. Patel, N.J. Roberts, S.J. Lloyd-Owen, R.J. Sapsford, and J.A. Wedzicha Airway epithelial inflammatory responses and clinical parameters in COPD Eur Respir J 22 1 2003 94 99
139. C. Schulz, K. Kratzel, K. Wolf, S. Schroll, M. Kohler, and M. Pfeifer Activation of bronchial epithelial cells in smokers without airway obstruction and patients with COPD Chest 125 5 2004 1706 1713
140. C. Schulz, K. Wolf, M. Harth, K. Kratzel, L. Kunz-Schughart, and M. Pfeifer Expression and release of interleukin-8 by human bronchial epithelial cells from patients with chronic obstructive pulmonary disease, smokers, and never-smokers Respiration 70 3 2003 254 261
141. C. Rusznak, P.R. Mills, J.L. Devalia, R.J. Sapsford, R.J. Davies, and S. Lozewicz Effect of cigarette smoke on the permeability and IL-1beta and sICAM-1 release from cultured human bronchial epithelial cells of never-smokers, smokers, and patients with chronic obstructive pulmonary disease Am J Respir Cell Mol Biol 23 4 2000 530 536
142. R.E. Russell, S.V. Culpitt, C. DeMatos, L. Donnelly, M. Smith, and J. Wiggins Release and activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by alveolar macrophages from patients with chronic obstructive pulmonary disease Am J Respir Cell Mol Biol 26 5 2002 602 609
143. R.E. Russell, A. Thorley, S.V. Culpitt, S. Dodd, L.E. Donnelly, and C. Demattos Alveolar macrophage-mediated elastolysis: roles of matrix metalloproteinases, cysteine, and serine proteases Am J Physiol Lung Cell Mol Physiol 283 4 2002 L867 L873
144. M. Tager, A. Piecyk, T. Kohnlein, U. Thiel, S. Ansorge, and T. Welte Evidence of a defective thiol status of alveolar macrophages from COPD patients and smokers. Chronic obstructive pulmonary disease Free Radic Biol Med 29 11 2000 (Dec) 1160 1165
145. P. Montuschi, S.A. Kharitonov, and P.J. Barnes Exhaled carbon monoxide and nitric oxide in COPD Chest 120 2 2001 496 501
146. M. Corradi, M. Majori, G.C. Cacciani, G.F. Consigli, E. de'Munari, and A. Pesci Increased exhaled nitric oxide in patients with stable chronic obstructive pulmonary disease Thorax 54 7 1999 572 575
147. K. Ansarin, J.M. Chatkin, I.M. Ferreira, C.A. Gutierrez, N. Zamel, and K.R. Chapman Exhaled nitric oxide in chronic obstructive pulmonary disease: relationship to pulmonary function Eur Respir J 17 5 2001 934 938
148. S.R. Rutgers, T.W. van der Mark, W. Coers, H. Moshage, W. Timens, and H.F. Kauffman Markers of nitric oxide metabolism in sputum and exhaled air are not increased in chronic obstructive pulmonary disease Thorax 54 7 1999 576 580
149. W. Maziak, S. Loukides, S. Culpitt, P. Sullivan, S.A. Kharitonov, and P.J. Barnes Exhaled nitric oxide in chronic obstructive pulmonary disease Am J Respir Crit Care Med 157 3 Pt 1 1998 998 1002
150. I.M. Ferreira, M.S. Hazari, C. Gutierrez, N. Zamel, and K.R. Chapman Exhaled nitric oxide and hydrogen peroxide in patients with chronic obstructive pulmonary disease: effects of inhaled beclomethasone Am J Respir Crit Care Med 164 6 2001 1012 1015
151. D.E. Euler, S.J. Dave, and H. Guo Effect of cigarette smoking on pentane excretion in alveolar breath Clin Chem 42 2 1996 303 308
152. P. Paredi, S.A. Kharitonov, D. Leak, S. Ward, D. Cramer, and P.J. Barnes Exhaled ethane, a marker of lipid peroxidation, is elevated in chronic obstructive pulmonary disease Am J Respir Crit Care Med 162 2 Pt 1 2000 369 373
153. P. Montuschi, J.V. Collins, G. Ciabattoni, N. Lazzeri, M. Corradi, and S.A. Kharitonov Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers Am J Respir Crit Care Med 162 3 Pt 1 2000 1175 1177
154. M. Corradi, A. Pesci, R. Casana, R. Alinovi, M. Goldoni, and M.V. Vettori Nitrate in exhaled breath condensate of patients with different airway diseases Nitric Oxide 8 1 2003 26 30
155. A. Kostikas, G. Papatheodorou, K. Psathakis, P. Panagou, and S. Loukides Oxidative stress in expired breath condensate of patients with COPD Chest 124 4 2003 (Oct) 1373 1380
156. M. Corradi, P. Montuschi, L.E. Donnelly, A. Pesci, S.A. Kharitonov, and P.J. Barnes Increased nitrosothiols in exhaled breath condensate in inflammatory airway diseases Am J Respir Crit Care Med 163 4 2001 854 858
157. P. Montuschi, S.A. Kharitonov, G. Ciabattoni, and P.J. Barnes Exhaled leukotrienes and prostaglandins in COPD Thorax 58 7 2003 585 588
158. K.W. Garey, M.M. Neuhauser, R.A. Robbins, L.H. Danziger, and I. Rubinstein Markers of inflammation in exhaled breath condensate of young healthy smokers Chest 125 1 2004 22 26
159. S.L. Traves, S.J. Smith, P.J. Barnes, and L.E. Donnelly Specific CXC but not CC chemokines cause elevated monocyte migration in COPD: a role for CXCR2 J Leukoc Biol 76 2 2004 441 450
160. W.D. Kim, W.S. Kim, Y. Koh, S.D. Lee, C.M. Lim, and D.S. Kim Abnormal peripheral blood T-lymphocyte subsets in a subgroup of patients with COPD Chest 122 2 2002 437 444
161. S.J. Hodge, G.L. Hodge, P.N. Reynolds, R. Scicchitano, and M. Holmes Increased production of TGF-beta and apoptosis of T lymphocytes isolated from peripheral blood in COPD Am J Physiol Lung Cell Mol Physiol 285 2 2003 L492 L499
162. I. Rahman, D. Morrison, K. Donaldson, and W. MacNee Systemic oxidative stress in asthma, COPD, and smokers Am J Respir Crit Care Med 154 4 Pt 1 1996 1055 1060
163. I. Rahman, E. Swarska, M. Henry, J. Stolk, and W. MacNee Is there any relationship between plasma antioxidant capacity and lung function in smokers and in patients with chronic obstructive pulmonary disease? Thorax 55 3 2000 189 193
164. T. Matsuse, Y. Fukuchi, H. Matsui, E. Sudo, T. Nagase, and H. Orimo Effect of cigarette smoking on pulmonary function in each phenotype M of alpha-1-protease inhibitor Chest 107 2 1995 395 400
165. T. Igishi, Y. Hitsuda, K. Kato, T. Sako, N. Burioka, and K. Yasuda Elevated urinary 8-hydroxydeoxyguanosine, a biomarker of oxidative stress, and lack of association with antioxidant vitamins in chronic obstructive pulmonary disease Respirology 8 4 2003 455 460
166. P.J. Stone, D.J. Gottlieb, G.T. O'Connor, D.E. Ciccolella, R. Breuer, and J. Bryan-Rhadfi Elastin and collagen degradation products in urine of smokers with and without chronic obstructive pulmonary disease Am J Respir Crit Care Med 151 4 1995 952 959
167. T. Hansel, and P. Barnes An atlas of COPD 2004 The Parthenon Publishing Group UK Lancaster